L’avis intitulé « Vaccin antigrippal FLUCELVAX : transition du vaccin antigrippal FLUCELVAX, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
eVhchcmW99MMw4pq
